Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience. - Pomponio MK; Burkbauer L; Goldbach M; Nazarian SM; Xie F; Clark AS; Matro JM; Fox KR; Shulman LN; Keele LJ; Tchou J (Journal of surgical oncology, 2020)